Group 1 - Intel's pre-market shares increased by 6% following SoftBank's announcement of a $2 billion equity investment in the company [2] - Palo Alto Networks saw a pre-market rise of over 5.5% after reporting a 16% year-over-year revenue growth to $2.54 billion for Q4 2024, exceeding the expected $2.5 billion [3] - Novo Nordisk's shares rose over 1% as the company significantly reduced the price of its diabetes treatment drug Ozempic for cash-paying patients in the U.S., now priced at less than half of the original price [4] - Xpeng Motors reported a total revenue of RMB 18.27 billion for Q2 2025, marking a 125.3% year-over-year increase and a 15.6% rise from Q1 2025 [5] - Apple has entered large-scale production of the iPhone 17, with Foxconn ramping up hiring at its Zhengzhou factory [6] Group 2 - Elon Musk's supercomputer cluster in Memphis is expected to have a total investment of $40 billion, powered by over 208 Tesla Megapack energy storage systems for his AI startup xAI [7] - CoreWeave's acquisition plan for Core Scientific is facing obstacles as its largest shareholder, Two Seas Capital, publicly opposed the offer, claiming it severely undervalues Core Scientific's assets [8] - S&P maintained the U.S. sovereign credit rating at "AA+/A-1+" with a stable outlook, citing that tariffs implemented during the Trump administration help mitigate recent fiscal shortfalls from tax cuts and spending bills [9]
三大期指涨跌不一，英特尔涨幅扩大至6%，软银将向其投资20亿美元；标普维持美国主权信用评级，展望保持稳定【美股盘前】